Contract notice: Nusinersen 12 Mg, Injection Solution Medicinal products for the musculo-skeletal system Short Description: Nusinersen 12 mg, the injection solution is indicated for the treatment of 5Q spinal muscle atrophy. One 5 ml vial contains Nusinersen sodium, which corresponds to 12 mg Nusinersen. One ml contains 2.4 mg Nusinersen. The recommended dose is 12 mg (5 ml) for one administration. Nusinersen treatment must start as soon as possible after the diagnosis of 4 saturation doses on 0, 14, 28 and 63. The maintenance dose should then be administered every 4 months. The expected amount for 12 months is 60 ampuls. Deadline for Submission: 20220404 10:00 Type of Buyer: Body governed by public law Type of Contract: Supplies Type of Procedure: Open procedure Regulation: European Union, with participation by GPA countries Type of Bid: Submission for all lots Award Criteria: Lowest price [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
